Accessibility Menu

How to Invest in Ozempic

By Rachel WarrenUpdated Jun 25, 2025 at 1:30 PM | Fact-checked by Frank Bass

Key Points

  • Ozempic, a type 2 diabetes treatment, presents investment opportunities via Novo Nordisk stock.
  • Projected GLP-1 market growth to almost $160 billion by early the 2030s indicates long-term sector potential.
  • Eli Lilly and Viking Therapeutics are other key players in the expanding GLP-1 market, offering diverse investment choices.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.